An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 910 participants.
Also called NCT01281306
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 910 participants
- Sponsor
- Registry
-
NCT01281306
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Canada, Hungary, India, Romania, Slovakia, South Korea, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01281306. Randomized; double masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-12 (actual). Results posted on 2015-08-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
- Condition
- Systolic Hypertension
- Intervention (Drug)
- LCZ696
- Intervention (Drug)
- Valsartan
- Intervention (Drug)
- AHU377
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct01281306- Content hash
46e08afe592accd5d93a38fd3dbea857fb2eceb54ff07399b4c1f46670bad2fc